文献速递血栓与止血

首次无诱因静脉血栓栓塞症年轻患者中确诊抗磷脂综合征的患病率

Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism.
PubMed 文献 · J Thromb Haemost · 2020-02-17

该横断面研究基于口服抗凝药剂量管理项目数据,纳入2002至2011年间524例18至50岁首次近端无诱因静脉血栓栓塞症患者,其中491例接受抗磷脂综合征检测,44例(9.0%,95%CI 6.7-11.8)符合Sapporo修订标准。研究提示年轻首次无诱因VTE患者中抗磷脂综合征患病率较高,在直接口服抗凝药时代如何检测抗磷脂综合征值得进一步研究。

要点

  • 18至50岁首次无诱因VTE患者中抗磷脂综合征患病率为9.0%(95%CI 6.7-11.8)
  • 抗磷脂综合征与非抗磷脂综合征患者在性别和VTE类型上无差异
  • 抗磷脂综合征女性VTE时口服避孕药使用比例低于非抗磷脂综合征女性(30.8%对55.1%,P=.02)

核心结论

  • 年轻首次无诱因VTE患者中抗磷脂综合征患病率较高,直接口服抗凝药时代抗磷脂综合征检测时机与方式值得进一步研究。

主要发现

  • 491例检测者中44例(9.0%,95%CI 6.7-11.8)符合Sapporo修订的抗磷脂综合征标准。
  • 26例抗磷脂综合征女性中8例(30.8%)VTE时使用复方口服避孕药,非抗磷脂综合征女性为108例(55.1%),P=.02。
  • 抗磷脂综合征与非抗磷脂综合征患者在性别或VTE类型上无差异。

关键数值与推荐

  • 抗磷脂综合征诊断采用Sapporo修订标准。
  • 抗磷脂综合征患病率9.0%(95%CI 6.7-11.8),对象为491例接受检测的18至50岁首次无诱因VTE患者。

临床怎么用

  • 对18至50岁首次无诱因VTE患者应考虑筛查抗磷脂综合征,检测时机与方案需结合直接口服抗凝药使用情况个体化决定。

局限性

  • 为单中心口服抗凝药管理项目数据的横断面分析,491/524例接受检测,非全部患者均检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antiphospholipid syndrome (APS) is an acquired thrombophilia disorder with prevalence not completely known in patients with first unprovoked venous thromboembolic events (VTE). Recent data suggest that the management of some APS patients should be different from that of patients with other thrombophilia. Our aim was to estimate the prevalence of APS in a community-based cohort of patients with a first unprovoked VTE. METHODS: We conducted a cross-sectional study analyzing data from our computer assisted oral anticoagulant dosage program. Data of all consecutive patients aged 18 to 50 years who were seen between January 1, 2002 and December 31, 2011 for a first proximal unprovoked VTE were extracted. The prevalence and main features of patients who fulfilled the Sapporo revised criteria for APS were collected. RESULTS AND DISCUSSION: A total of 524 incident patients aged 18 to 50 years were included in the anticoagulation clinic during the study period. Of them, 491 were tested for APS and 44 (9.0%; 95% confidence interval [CI]: 6.7-11.8) fulfilled APS criteria. Of 26 APS women, 8 (30.8%) were on combined oral contraceptive pill at the time of VTE, versus 108 (55.1%) in non-APS women (P = .02). No difference was observed between APS and non-APS patients in terms of gender or type of VTE. The prevalence of APS is high in young patients with a first unprovoked VTE. In the direct oral anticoagulant era, when and how to test for APS is challenging and deserves further investigation.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Miranda S, Park J, Le Gal G, et al. Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2020. PMID: 31872492. doi:10.1111/jth.14720

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。